256 related articles for article (PubMed ID: 23230289)
1. Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.
Fagnocchi L; Biolchi A; Ferlicca F; Boccadifuoco G; Brunelli B; Brier S; Norais N; Chiarot E; Bensi G; Kroll JS; Pizza M; Donnelly J; Giuliani MM; Delany I
Infect Immun; 2013 Feb; 81(2):560-9. PubMed ID: 23230289
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
Rossi R; Beernink PT; Giuntini S; Granoff DM
Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
[TBL] [Abstract][Full Text] [Related]
3. Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.
Green LR; Lucidarme J; Dave N; Chan H; Clark S; Borrow R; Bayliss CD
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950334
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.
Frosi G; Biolchi A; Lo Sapio M; Rigat F; Gilchrist S; Lucidarme J; Findlow J; Borrow R; Pizza M; Giuliani MM; Medini D
Vaccine; 2013 Oct; 31(43):4968-74. PubMed ID: 23954380
[TBL] [Abstract][Full Text] [Related]
5. Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.
Muzzi A; Lu M-C; Mori E; Biolchi A; Fu T; Serino L
mSphere; 2024 Jun; 9(6):e0022024. PubMed ID: 38752729
[No Abstract] [Full Text] [Related]
6. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
7. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
[TBL] [Abstract][Full Text] [Related]
8. NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies.
Liguori A; Dello Iacono L; Maruggi G; Benucci B; Merola M; Lo Surdo P; López-Sagaseta J; Pizza M; Malito E; Bottomley MJ
mBio; 2018 Oct; 9(5):. PubMed ID: 30327444
[No Abstract] [Full Text] [Related]
9. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
10. High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
Waśko I; Hong E; De Paola R; Stella M; Moschioni M; Taha MK; Skoczyńska A
Vaccine; 2016 Jan; 34(4):510-515. PubMed ID: 26686998
[TBL] [Abstract][Full Text] [Related]
11. Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease.
Watson PS; Novy PL; Friedland LR
Int J Infect Dis; 2019 Aug; 85():22-27. PubMed ID: 31102824
[TBL] [Abstract][Full Text] [Related]
12. The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential.
Hung MC; Heckels JE; Christodoulides M
mBio; 2013 Feb; 4(2):. PubMed ID: 23443003
[TBL] [Abstract][Full Text] [Related]
13. Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.
Law DK; Lefebvre B; Gilca R; Deng S; Zhou J; De Wals P; Tsang RS
BMC Microbiol; 2015 Jul; 15():143. PubMed ID: 26204985
[TBL] [Abstract][Full Text] [Related]
14. Molecular Basis of Ligand-Dependent Regulation of NadR, the Transcriptional Repressor of Meningococcal Virulence Factor NadA.
Liguori A; Malito E; Lo Surdo P; Fagnocchi L; Cantini F; Haag AF; Brier S; Pizza M; Delany I; Bottomley MJ
PLoS Pathog; 2016 Apr; 12(4):e1005557. PubMed ID: 27105075
[TBL] [Abstract][Full Text] [Related]
15. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.
Pajon R; Lujan E; Granoff DM
Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis.
Savitskaya VY; Dolinnaya NG; Strekalovskikh VV; Peskovatskova ES; Snyga VG; Trefilov VS; Monakhova MV; Kubareva EA
Med Sci (Basel); 2023 Dec; 11(4):. PubMed ID: 38132917
[No Abstract] [Full Text] [Related]
17. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.
Serruto D; Bottomley MJ; Ram S; Giuliani MM; Rappuoli R
Vaccine; 2012 May; 30 Suppl 2(0 2):B87-97. PubMed ID: 22607904
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study.
Perrett KP; McVernon J; Richmond PC; Marshall H; Nissen M; August A; Percell S; Toneatto D; Nolan T
Vaccine; 2015 Sep; 33(39):5217-24. PubMed ID: 26232542
[TBL] [Abstract][Full Text] [Related]
19. The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.
Masignani V; Pizza M; Moxon ER
Front Immunol; 2019; 10():751. PubMed ID: 31040844
[TBL] [Abstract][Full Text] [Related]
20. Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica.
Lucidarme J; Gilchrist S; Newbold LS; Gray SJ; Kaczmarski EB; Richardson L; Bennett JS; Maiden MC; Findlow J; Borrow R
Clin Vaccine Immunol; 2013 Sep; 20(9):1360-9. PubMed ID: 23803905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
